Advanced Search

 

Study ID Status Title Patient Level Data
FNM40001 Completed A multi-centre, randomised, double blind, placebo controlled, parallel group study examining the effect of fluticasone propionate aqueous nasal spray (200mcg od) and/or inhaled fluticasone propionate (250mcg bd) in pollen induced asthma and rhinits.
FNM40017 Completed A Multi-Center, Randomized, Double-Blind, Parallel Gruop Study to Assess the Potential Growth Effects of a One-year Course of Fluticasone Propionate Aqueous Nasal Spray (200mcg QD) versus Placebo in Pre-pubescent, Pediatric Subjects with Perennial Allergic Rhinitis Study Listed on ClinicalStudyDataRequest.com
FNM40027 Completed Intranasal fluticasone propionate 200?g once daily versus 200?g twice daily in severe ragweed allergic rhinitis.
FNM40030 Completed Fluticasone propionate aqueous nasal spray treatment for perennial allergic rhinitis in children.
FNM40044 Completed A study to investigate the effect of intranasal fluticasone propionate in more detail during nasal allergen provocation in patients with an isolated grass pollen allergy.Extensive searching has see citation below.
FNM40054 Completed A placebo controlled trial during the pollen season comparing the effects of intranasal beclomethasone dipropionate and fluticasone propionate in children and young adults with asthma and allergic rhinitis.Extensive searching has revealed that no clinical report is available for this study.
FNM40071 Completed A double-blind, double-dummy, parallel-group trial: fluticasone once daily versus loratadine once daily in pollinic rhinitis
FNM40072 Completed Intranasal Fluticasone Once Daily Compared with Once-Daily Cetirizine in the Treatment of Seasonal Allergic Rhinitis.Extensive searching has revealed that no clinical study report is available for this study. The clinical trial results were reported via publication; see citation below.
FNM40079 Completed A study to investigate the effect of intranasal fluticasone propionate in more detail during nasal allergen provocation in patients with an isolated grass pollen allergy.Extensive searching has revealed that no clinical report is available for this study.
FNM40083 Completed Intranasal fluticasone proprionate does not prevent acute otitis media during viral upper respiratory infection in children.Extensive searching has revealed that no clinical study report is available for this study. The clinical trial results were reported via publication; see citation below.
FNM40108 Completed Continuous therapy with fluticasone-nasal spray (200mg) versus oral cetirizine (10mg) in patients with seasonal allergic rhinitis: Comparison of effects of a pre- and coseasonal treatment on symptoms, quality of life and cytokines and mediators in nasal secretion.
FNM40123 Completed A double-blind, randomized, placebo-controlled study of the efficacy and safety of fluticasone propionate aqueous 200mcg QD versus beclomethasone aqueous 168mcg BID versus placebo by intranasal administration for two weeks in adult patients with seasonal allergic rhinitis in the mountain cedar s ...
FNM40137 Completed The common cold: Effects of intranasal fluticasone propionate treatment.Extensive searching has revealed that no clinical study report is available for this study. The clinical trial results were reported via publication; see citation below.
FNM40138 Completed Intranasal fluticasone propionate vs. beclomethasone dipropionate in the treatment of adult patients with perennial allergic rhinitis. A multi-centre, randomized, double-blind, parallel-group study.
FNM40173 Completed Intranasal fluticasone propionate vs loratadine in the treatment of adolescent patients with seasonal allergic rhinitis.
FNM40178 Completed A double blind, parallel armed, randomised, controlled trial into the non-surgical management of adenotonsillar hypertrophy.Extensive searching has revealed that no clinical study report is available for this study. The clinical trial results were reported via publication; see citation below.
FNM40181 Completed A single centre, randomised, double blind, cross over study to investigate longitudinal growth using knemometry in children with seasonal and perennial rhinitis during treatment with fluticasone propionate aqueous nasal spray (FPANS) 100mcg/day and placebo.
FNM40183 Completed A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Potential Effects of a Six-Week Course of Fluticasone Propionate Aqueous Nasal Spray (200mcg QD) on the HPA-Axis in 2 and <4 Year Old Subjects with Allergic Rhinitis.
FNM40184 Completed A Multicenter, randomized, double-blind, parallel-group study examining the effect of fluticasone propionate aqueous nasal spray 200mcg QD in subjects with sinus pain and pressure associated with nasal congestion due to allergic rhinitis
FNM40185 Completed A multicenter, randomized, double-blind, parallel group study examining the effect of fluticasone proprionate aqueous nasal spray 200mcg QD in subjects with sinus pain and pressure associated with nasal congestion due to allergic rhinitis
FNM40188 Completed An open study to evaluate the efficacy and tolerability of Flixonase ™ Aqueous Nasal Spray after switching from Rhinocort (Aqueous Nasal Spray or Turbuhaler) as a maintenance therapy for the treatment of perennial allergic rhinitis (PAR).
FNM40194 Completed A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Two-Week Study Assessing the Efficacy of Fluticasone Propionate Aqueous Nasal Spray 200mcg every day Versus Montelukast 10mg every day in Subjects ≥15 Years Old with Seasonal Allergic Rhinitis (SAR) Study Listed on ClinicalStudyDataRequest.com
FNM40195 Completed A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Two-Week Study Assessing the Efficacy of Fluticasone Propionate Aqueous Nasal Spray 200mcg every day Versus Montelukast 10mg every day in Subjects ≥15 Years Old with Seasonal Allergic Rhinitis (SAR) Study Listed on ClinicalStudyDataRequest.com
FNP30002 Completed Single-centre, randomised, double-blind study to determine the efficacy (and tolerability) of fluticasone propionate nasal drops 400mg OD and placebo in adult patients with nasal polyps or chronic sinusitis.Extensive searching has revealed that no clinical study report is available for this study.
FNP40010 Completed A single centre, randomised, double blind, parallel group study to determine the efficacy and tolerability of Fluticasone propionate nasal drops (Nasules) 400mcg bd, 400mcg od and placebo nasal drops in adult patients with bilateral polyposis. Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.